A Phase I Study of DMS612, a Novel Bi-functional Alkylating Agent

PURPOSE: DMS612 is a dimethane sulfonate analog with bifunctional alkylating activity and preferential cytotoxicity to human renal cell carcinoma (RCC) in the NCI-60 cell panel. This first-in-human phase I study aimed to determine dose-limiting toxicity (DLT), maximum tolerated dose (MTD), pharmacok...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Appleman, Leonard J., Balasubramaniam, Sanjeeve, Parise, Robert A, Bryla, Christine, Redon, Christophe E., Nakamura, Asako J., Bonner, William M., Wright, John J, Piekarz, Richard, Kohler, David R, Jiang, Yixing, Belani, Chandra P., Eiseman, Julie, Chu, Edward, Beumer, Jan H., Bates, Susan E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4755291/
https://ncbi.nlm.nih.gov/pubmed/25467180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-1333
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados